Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "continuous renal replacement therapy"

Renal Replacement Therapy Rates Declining in Some Countries

VIENNA — The need for renal replacement therapy has stabilized in many parts of the Western world, new registry data show. "There was a continuous increase in the incidence of renal replacement therapy from the 1980s until the early 2000s, and ... General Medicine eJournal, 1 day ago
[x]  

4 images for continuous renal replacement therapy

Medagadget.com, 1 month ago
Medagadget.com, 1 month ago
Medical News Today, 5 days ago
First Post.com, 1 month ago

Critically Ill Acute Kidney Injury Patients Benefit from Early RRT

Share this content: Early initiation of renal replacement therapy (RRT) significantly improves 90-day survival among critically ill patients with acute kidney injury (AKI), researchers reported at the European Renal Association-European Dialysis ...
 Renal & Urology News6 days ago Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit  New England Journal of Medicine2 weeks ago Risk Factors ID'd for Early Mortality After Starting CRRT  Renal & Urology News2 days ago Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients  New England Journal of Medicine2 days ago

Prognosis of extremely severe lactic acidosis in metformin-treated patients with septic shock: continuous (?) renal replacement therapy in the spotlight!

K.Doenyas-Barak , I.Beberashvili and S.Efrati The role of RRT in the treatment of lactic acidosis in general, and in metformin-associated lactic acidosis (MALA) in particular, has been the subject of several trials. Due to the low molecular ...
 Critical Care3 weeks ago

Neutrophil gelatinase-associated lipocalin elimination by renal replacement therapy: minding the membrane!

Letter Open Access Critical Care 2016 20 :87 DOI: 10.1186/s13054-016-1258-9 Honore and spapen.2016 Published: 5April2016 The Letter to this article has been published in Critical Care 2016 20 :20 This comment refers to ...
 Critical Care1 month ago

AMIA APD Momentum Drives Baxter's Renal Business Growth in 1Q16

Baxter's 1Q16 Earnings Beat Estimates, Post Improved Margins ( Continued from Prior Part ) 1Q16 performance Baxter International (BAX) reported ~$2.4 billion in total revenues in 1Q16. Of that, ~$898 million, or ~38%, came from Baxter's Renal ...
 Yahoo! Finance UK and Ireland2 weeks ago
[x]  

Patient Dosing Initiated for OMS721 Phase 2 Program in Renal Diseases

SEATTLE--( BUSINESS WIRE )--Omeros Corporation(NASDAQ: OMER) today announced initiation of patient dosing in its OMS721 Phase 2 program in corticosteroid-dependent renal diseases. The Phase 2 clinical trial of OMS721, the company's lead ...
 Business Wire1 month ago Omeros Corporation Release: Patient Dosing Initiated For OMS721 Phase 2 Program In Renal Diseases  BioSpace1 month ago OMEROS : Patient Dosing Initiated for OMS721 Phase 2 Program in Renal Diseases  4 Traders1 month ago
[x]  

Monitoring of Potential Safety Events and Vital Signs during Active Mobilization of Patients Undergoing Continuous Renal Replacement Therapy in a Medical Intensive Care Unit

Background/Aims: This study aims to evaluate potential safety events and vital sign changes during active mobilization physical therapy (PT) in critically ill patients undergoing continuous renal replacement therapy (CRRT). Methods: A retrospective ...
 Blood Purification1 week ago

Biotech Forum Daily Digest: The Biotech Rally Continues, Relypsa Gets Some Traction, Exelixis Living Up To Its Promise.

Biotech continues to build on the strength it demonstrated last week and biotech indices surged over two percent on Tuesday after a solid start to the week on Monday. Monday's rise was mainly led by the small cap names in the sector, probably helped ...
 Seeking Alpha4 days ago

Aytu BioScience Acquires U.S. Commercial Rights To Natesto

Aytu BioScience Enters $2 Billion Testosterone Replacement Market With Acquisition Of U.S. Commercial Rights To Natesto ENGLEWOOD, Colo. , April 25, 2016 /PRNewswire/ —Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company ...
 Pharma Live1 month ago Aytu BioScience, Inc. (AYTU: OTCQX U.S. Premier) | Aytu BioScience Enters $2 Billion Testosterone Replacement Market with Acquisition of U.S. Commercial Rights to Natesto®  OTC Markets1 month ago Aytu BioScience Enters $2 Billion Testosterone Replacement Market with Acquisition of U.S. Commercial Rights to Natesto®  Bloomberg1 month ago Aytu BioScience Enters 2 Billion Testosterone Replacement Market with Acquisition of US Commercial Rights to Natesto  Pharma Focus Asia1 month ago
[x]  

Bristol-Myers Squibb's Opdivo® (nivolumab) Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

PRINCETON, N.J.--(Business Wire)-- Bristol-Myers Squibb Company (NYSE: BMY) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Opdivo for the potential indication of recurrent or ...
 Digital Journal1 month ago Bristol-Myers Squibb's Opdivo(R) (nivolumab) Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck  TradingCharts.com1 month ago Merck Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for KEYTRUDA® (pembrolizumab) in Classical Hodgkin Lymphoma (cHL)  Yahoo! Singapore1 month ago MERCK : Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for KEYTRUDA® (pembrolizumab) in Classical Hodgkin Lymphoma (cHL)  4 Traders1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less